Indication
Hyperpigmentation
3 clinical trials
5 products
Clinical trial
A Randomized, Observer-Blinded, Vehicle-Controlled Study on the Safety and Efficacy of Twice Daily Application of Ruboxistaurin (DBI-102) Gel Vs.Vehicle Gel Vs. Hydroquinone Cream on Sun-Exposed and Sun-Protected Skin of AdultsStatus: Completed, Estimated PCD: 2023-03-07
Product
Vehicle gelProduct
HydroquinoneProduct
DBI-102Clinical trial
Comparison of the Effectiveness of Brightening Creams vs Laser Therapy (QS Nd:YAG 1064nm Laser) in Skin Hyperpigmentation After Sclerotherapy by Objective Measurement: A Randomized Controlled Monocentric TrialStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Triple creamClinical trial
A Control Trial of the Efficacy and Safety of 0.025% Tretinoin Cream and Cream Based in the Treatment of Axillary Hyperpigmentation Associated With Acanthosis NigricansStatus: Recruiting, Estimated PCD: 2024-05-01
Product
Tretinoin